Literature DB >> 26085993

Riboflavin concentration in corneal stroma after intracameral injection.

Na Li1, Xiu-Jun Peng2, Zheng-Jun Fan2, Xu Pang2, Yu Xia2, Teng-Fei Wu2.   

Abstract

AIM: To evaluate the enrichment of riboflavin in the corneal stroma after intracameral injection to research the barrier ability of the corneal endothelium to riboflavin in vivo.
METHODS: The right eyes of 30 New Zealand white rabbits were divided into three groups. Different concentrations riboflavin-balanced salt solutions (BSS) were injected into the anterior chamber (10 with 0.5%, 10 with 1%, and 10 with 2%). Eight corneal buttons of 8.5 mm in diameter from each group were dissected at 30min after injection and the riboflavin concentrations in the corneal stroma were determined using high-performance liquid chromatography (HPLC) after removing the epithelium and endothelium. The other two rabbits in every group were observed for 24h and sacrificed. As a comparison, the riboflavin concentrations from 16 corneal stromal samples were determined using HPLC after instillation of 0.1% riboflavin-BSS solution for 30min on the corneal surface (8 without epithelium and 8 with intact epithelium).
RESULTS: The mean riboflavin concentrations were 11.19, 18.97, 25.08, 20.18, and 1.13 µg/g for 0.5%, 1%, 2%, de-epithelialzed samples, and the transepithelial groups, respectively. The color change of the corneal stroma and the HPLC results showed that enrichment with riboflavin similar to classical de-epithelialized corneal collagen crosslinking (CXL) could be achieved by intracameral 1% riboflavin-BSS solution after 30min; the effect appeared to be continuous for at least 30min.
CONCLUSION: Riboflavin can effectively penetrate the corneal stroma through the endothelium after an intracameral injection in vivo, so it could be an enhancing method that could improve the corneal riboflavin concentration in transepithelial CXL.

Entities:  

Keywords:  cornea; endothelium; high-performance liquid chromatography; intracameral injection; riboflavin

Year:  2015        PMID: 26085993      PMCID: PMC4458648          DOI: 10.3980/j.issn.2222-3959.2015.03.07

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  26 in total

Review 1.  Ocular drug delivery.

Authors:  Ripal Gaudana; Hari Krishna Ananthula; Ashwin Parenky; Ashim K Mitra
Journal:  AAPS J       Date:  2010-05-01       Impact factor: 4.009

Review 2.  Safety of UVA-riboflavin cross-linking of the cornea.

Authors:  Eberhard Spoerl; Michael Mrochen; David Sliney; Stephen Trokel; Theo Seiler
Journal:  Cornea       Date:  2007-05       Impact factor: 2.651

3.  Collagen cross-linking in early keratoconus with riboflavin in a femtosecond laser-created pocket: initial clinical results.

Authors:  Anastasios John Kanellopoulos
Journal:  J Refract Surg       Date:  2009-11       Impact factor: 3.573

4.  Analysis of riboflavin and riboflavin cofactor levels in plasma by high-performance liquid chromatography.

Authors:  C D Capo-chichi; J L Guéant; F Feillet; F Namour; M Vidailhet
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-02-28

Review 5.  Crosslinking treatment of progressive keratoconus: new hope.

Authors:  Gregor Wollensak
Journal:  Curr Opin Ophthalmol       Date:  2006-08       Impact factor: 3.761

6.  Corneal cross-linking: intrastromal riboflavin concentration in iontophoresis-assisted imbibition versus traditional and transepithelial techniques.

Authors:  Leonardo Mastropasqua; Mario Nubile; Roberta Calienno; Peter A Mattei; Emilio Pedrotti; Niccolò Salgari; Rodolfo Mastropasqua; Manuela Lanzini
Journal:  Am J Ophthalmol       Date:  2013-12-07       Impact factor: 5.258

7.  Corneal crosslinking with riboflavin and ultraviolet A. Part II. Clinical indications and results.

Authors:  Frederik Raiskup; Eberhard Spoerl
Journal:  Ocul Surf       Date:  2013-01-28       Impact factor: 5.033

8.  Corneal crosslinking: riboflavin concentration in corneal stroma exposed with and without epithelium.

Authors:  Stefano Baiocchi; Cosimo Mazzotta; Daniela Cerretani; Tomaso Caporossi; Aldo Caporossi
Journal:  J Cataract Refract Surg       Date:  2009-05       Impact factor: 3.351

9.  Effect of complete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy.

Authors:  Sally Hayes; David P O'Brart; Letitia S Lamdin; James Doutch; Kostas Samaras; John Marshall; Keith M Meek
Journal:  J Cataract Refract Surg       Date:  2008-04       Impact factor: 3.351

10.  Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA).

Authors:  A Scott McCall; Stefan Kraft; Henry F Edelhauser; George W Kidder; Richard R Lundquist; Helen E Bradshaw; Zinaida Dedeic; Megan J C Dionne; Ethan M Clement; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-30       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.